Acute metabolic changes in plasma membrane (PM) lipids, such as those mediating signalling reactions, are rapidly compensated by homeostatic responses whose molecular basis is poorly understood. Here we show that the extended synaptotagmins (E-Syts), endoplasmic reticulum (ER) proteins that function as PtdIns(4,5)P 2 -and Ca 2+ -regulated tethers to the PM, participate in these responses. E-Syts transfer glycerolipids between bilayers in vitro, and this transfer requires Ca 2+ and their lipid-harbouring SMP domain. Genome-edited cells lacking E-Syts do not exhibit abnormalities in the major glycerolipids at rest, but exhibit enhanced and sustained accumulation of PM diacylglycerol following PtdIns(4,5)P 2 hydrolysis by PLC activation, which can be rescued by expression of E-Syt1, but not by mutant E-Syt1 lacking the SMP domain. The formation of E-Syt-dependent ER-PM tethers in response to stimuli that cleave PtdIns(4,5)P 2 and elevate Ca 2+ may help reverse accumulation of diacylglycerol in the PM by transferring it to the ER for metabolic recycling.
Note the strong homo-and heterodimerization of endogenously tagged E-Syt1 with endogenous E-Syt1, E-Syt2 and E-Syt3. (f) Time course of normalized GFP signal, as assessed by total internal reflection fluorescence (TIRF) microscopy, from cells expressing endogenously tagged E-Syt1 as well as muscarinic M1 receptor (M1R) and the PtdIns(4,5)P 2 probe, mRFP-PH-PLCδ. Oxo-M (10 µM) stimulation and atropine (50 µM) application are indicated. The biphasic response of E-Syt1 reflects the increase in cytosolic Ca 2+ immediately followed by massive PtdIns(4,5)P 2 depletion (mean ± s.e.m., n = 16 cells pooled from two independent experiments). (g-j) Confocal images of live clone no. 21 cells before and 1.5 min after stimulation with ionomycin (2 µM; g), and before and 4 min after stimulation with thapsigargin (2 µM; i); the time course of ionomycininduced (h) and thapsigargin-induced (i) recruitment of endoEGFP-E-Syt1 to the PM, as assessed by TIRF microscopy, is also shown (mean ± s.e.m., n = 8 cells (h) and 11 cells (j) assessed from one experiment that was repeated independently three times with similar results). Scale bars, 10 µm. Unprocessed original scans of blots are shown in Supplementary  Fig. 7 .
synthesized lipids from the ER to the PM and/or of lipid metabolites from the PM to the ER for metabolic recycling. As their tethering properties are regulated by Ca 2+ , their functions may be important in maintaining or resetting lipid homeostasis in response to acute physiological changes that produce PM lipid perturbations.
The goal of this study was to directly test the lipid transfer properties of the E-Syts and to begin determining their impact on lipid homeostasis at the PM in living cells.
RESULTS
Endogenous E-Syt1 is rapidly translocated to ER-PM contacts on cytosolic Ca 2+ increase Previous E-Syt localization studies had capitalized on exogenously expressed tagged proteins. We have now generated polyclonal antibodies against the N terminus of human E-Syt1, which on affinity-purification labelled specifically the endogenous protein in HeLa cells not only by western blotting ( Supplementary Fig. 1a ) but also by immunofluorescence (Fig. 1a ). The signal generated by these antibodies co-localized with mRFP-Sec61β (a marker of the ER membrane) and was absent in genome-edited HeLa cells lacking E-Syt1 (see below; Supplementary Fig. 1b ). The bulk of this immunoreactivity rapidly translocated to the cell cortex (peak of recruitment at about 2-3 min) after addition of the Ca 2+ ionophore ionomycin 25 (Fig. 1a) , confirming results obtained with exogenous tagged E-Syt1 ( Supplementary Fig. 1c,d) 8 .
To analyse the dynamics of E-Syt1 when expressed at endogenous levels, a HeLa cell line expressing tagged E-Syt1 from the endogenous locus was generated by inserting EGFP at its N terminus using CRISPR/Cas9-mediated genome editing (Fig. 1b) . Expression of the fusion protein (endoEGFP-E-Syt1) was confirmed by western blotting, which revealed a band reactive for both anti-GFP and anti-E-Syt1 antibodies in extracts of these cells (Fig. 1c ). This band, as well as EGFP fluorescence, disappeared on RNA interference (RNAi) against endogenous E-Syt1 ( Fig. 1c,d ). Further analysis demonstrated that this protein had the expected properties and dynamics 8 of E-Syt1. These included homodimerization as well as heterodimerization with other E-Syts ( Fig. 1e ) and Ca 2+ -dependent PM recruitment. This recruitment was very transient in response to the Ca 2+ elevation produced by muscarinic M1 receptor (M1R) activation by oxotremorine M (Oxo-M) in cells overexpressing M1R 26 , as this elevation is the result of PLCdependent inositol 1,4,5-trisphosphate generation 27, 28 and thus correlates with very rapid and massive PtdIns(4,5)P 2 depletion (Fig. 1f ). It was more persistent, as expected 8 , in response to Ca 2+ elevations produced by ionomycin (Fig. 1g,h and Supplementary Video 1), which induces a slower PtdIns(4,5)P 2 loss (see below) and to thapsigargin (Fig. 1i,j and Supplementary Video 2), which does not have a major impact on PtdIns(4,5)P 2 levels.
Ca 2+ -regulated E-Syt1-dependent lipid transport in vitro
The presence of the SMP domain in the E-Syts suggested a role for these proteins in lipid transfer 22 . To provide direct evidence for such a function, we tested the ability of the cytosolic domain of E-Syt1 to transfer lipids between liposomes using a fluorescence resonance energy transfer(FRET)-based assay ( Fig. 2a ). In this assay, donor liposomes comprising phosphatidylcholine (PC), a fluorescent dyelabelled lipid (NBD-phosphatidylethanolamine (PE) (Fig. 2b) ) and a nickel-conjugated lipid (DGS-NTA(Ni)), but no acidic phospholipids (and thus ER-like) were mixed with acceptor acidic phospholipidcontaining (PM-like) liposomes (PC, phosphatidylserine (PS) and PtdIns(4,5)P 2 ) and with the purified His-tagged cytosolic portion of E-Syt1 (E-Syt1 cyto ) ( Fig. 2a ). This construct becomes anchored to the donor liposomes by the His tag and binds PtdIns(4,5)P 2 -containing acceptor liposomes in trans, and in a Ca 2+ -dependent way, by means of its C2 domains ( Fig. 2a ).
In the absence of E-Syt1 cyto , NBD-PE was self-quenched in the donor liposomes, and solubilization of the liposomes with n-dodecyl-ß-D-maltoside resulted in an efficient dequenching ( Supplementary Fig. 2a ).
Addition of E-Syt1 cyto and of various Ca 2+ concentrations (5 to 200 µM) to the donor plus acceptor liposome mixture induced rapid dequenching of NBD-PE in a Ca 2+ -dependent manner, consistent with the transfer of NBD-PE from donor to acceptor liposomes ( Fig. 2c,d ). Fluorescent lipids (1%) and 100 µM Ca 2+ were used in subsequent transfer assays. Absence of PtdIns(4,5)P 2 in the acceptor liposomes markedly slowed the dequenching of NBD-PE ( Supplementary Fig. 2b ). Furthermore, lipid transfer was bidirectional, as incorporating NBD-PE in either the ER-like or the PM-like liposomes, that is, reverting donor and acceptor liposomes, resulting in dye dequenching with the same efficiency ( Supplementary  Fig. 2c ). NBD-PE dequenching was not due to membrane fusion as a similar assay in which the fluorescent lipid tag in the donor liposomes was replaced by a water-soluble luminal self-quenching dye (sulforhodamine B) revealed no content mixing of the liposomes ( Supplementary Fig. 2d ). Potential lipid mixing due to hemifusion as a result of liposome tethering was ruled out: as revealed by turbidity assay, the potent liposome tethering produced by E-Syt1 cyto could be completely reversed by the addition of a cocktail of EDTA, imidazole and proteinase K ('Cocktail'; ( Fig. 2e ,h top panels). Furthermore, a mutant E-Syt1 cyto lacking the SMP domain (E-Syt1 cyto ∆SMP) had negligible lipid transfer activity, although its liposome tethering properties were only slightly reduced relative to E-Syt1 cyto ( Fig. 2e ). This minor reduction could have been explained by the lack of SMPdependent dimerization ( Fig. 2e ). Finally, replacing two hydrophobic residues (Val169 and Leu308) lining the lipid-binding groove of the SMP domain 22 with the bulky hydrophobic amino acid tryptophan strongly impaired lipid (NBD-PE) binding and transfer activity ( Fig. 2f ,g) without affecting liposome tethering ( Fig. 2h ).
Changing the ratio of donor and acceptor liposomes, from 1:9 to 1:1, significantly reduced the maximum dequenching efficiency achieved at the end of the assay ( Supplementary Fig. 2e ), indicating that E-Syt1 transfer glycerolipids along a concentration gradient. Furthermore, addition of non-labelled PE to acceptor liposomes did not affect NBD-PE transfer ( Supplementary Fig. 2f ), as PE is not preferred over other glycerolipids present in the liposome mixture (all glycerolipids are transported bidirectionally).
Having validated the hypothesis that an E-Syt has lipid transfer activity, we explored the role of the E-Syts in lipid dynamics and homeostasis with a gene knockout (KO) approach.
Generation of E-Syt1/2 DKO and E-Syt1/2/3 TKO HeLa cells using TALEN and CRISPR
We first disrupted the E-Syt2 gene in HeLa cells using transcription activator-like effector nuclease (TALEN) and then sequentially the E-Syt1 and the E-Syt3 genes in these cells using the CRISPR/Cas9 system ( Fig. 3a and Supplementary Fig. 3a -c and see Methods for details).
Absence of the E-Syt1 and E-Syt2 bands in western blots of extracts of two E-Syt1/2 double-KO clones (DKO:6-8 and DKO:7-5) is shown in Fig. 3b , and the loss of E-Syt1 immunofluorescence in the DKO:6-8 clone is shown in Supplementary Fig. 1b (see also Supplementary Fig. 3d -g). Given the low expression level of endogenous E-Syt3, validation of its absence in triple-KO (TKO) cells required an enrichment procedure. To this end, we expressed EGFPtagged E-Syt2 as a bait for E-Syt3 with which it heterodimerizes: anti-GFP immunoprecipitates obtained from these cells were enriched in the E-Syt3 immunoreactive band only when generated from cells where the E-Syt3 gene had not been edited, irrespective of the expression of the other endogenous E-Syts ( Fig. 3b , see also Supplementary Fig. 3h No obvious defects were observed in cell viability and overall morphology of KO cells, with the exception of a slower growth relative to parental HeLa cells. However, more detailed analysis revealed some changes, as described below. Initial experiments were carried out in E-Syt1/2 DKO cells. Subsequently, selected experiments were repeated in E-Syt TKO cells with similar (6) E-Syt1 (7) CRISPR/Cas9 Ca 2+ enhanced apposition of the ER to the PM is impaired in E-Syt KO cells
As a premise to study the impact of the E-Syts on lipid dynamics, we assessed whether absence of the E-Syts had an impact on the ER in response to a rise in cytosolic Ca 2+ . As reported, in wild-type (WT) cells, elevation of cytosolic Ca 2+ results in increased fluorescence for the luminal ER marker (ER-oxGFP) in total internal reflection fluorescence (TIRF) microscopy, most likely reflecting an expansion of areas of apposition between the ER and the PM 8 . To assess the impact of the lack of the E-Syts on such a response, changes of the ER-oxGFP fluorescence following muscarinic receptor stimulation by Oxo-M were monitored in control and TKO cells also transfected with the muscarinic M1 receptor (M1R). In E-Syt TKO cells, the Ca 2+ -dependent increase of ER-oxGFP fluorescence (which is very transient owing to concomitant PtdIns(4,5)P 2 loss) was abolished and this effect could be 'rescued' , in fact resulting in exaggeration of recruitment, by exogenous expression of E-Syt1 along with Myc-E-Syt2 ( Fig. 3c ) (note that the E-Syt1/E-Syt2 heterodimer is predominantly localized throughout the ER at resting Ca 2+ levels, in contrast to the E-Syt2 homodimer that is already concentrated at the ER-PM contact sites at resting Ca 2+ levels 8 ). Near absence of the E-Syts does not inhibit store-operated calcium entry 8, 12 , thus ruling out impaired Ca 2+ elevations as the cause of the defective increase of ER-oxGFP fluorescence.
The steady-state glycerolipid composition of the PM is not affected in E-Syt KO cells
The SMP domain of the E-Syts harbours glycerophospholipids 22 and can transfer them in vitro between artificial membranes (see above).
As the E-Syts form ER-PM tethers, they may exchange such lipids between these two membranes.
To assess the impact of E-Syts in the control of steady-state PM lipid levels, we applied with some modifications a method for the rapid separation and purification of PMs from cultured cells 29 . HeLa cells in suspension were mixed with poly-D-lysine-coated dextran beads and the mixture was incubated overnight to allow the cells to adhere to the beads (Fig. 4a,c,d ). The beads were then exposed to a hypotonic solution to induce osmotic lysis, vigorously vortexed and briefly sonicated to remove most organelles from the PM sheets that remained tightly attached to the bead surface and could be visualized by NBD-labelled sphingomyelin ( Fig. 4b ,e, and see Methods). As shown by western blotting, the material that remained bound to the beads was very strongly enriched relative to the starting material in PM marker proteins (CD44 and Na + /K + -ATPase). Other proteins tested partitioned roughly as expected. PM receptors (epidermal growth factor receptor (EGFR) and transferrin receptor (TfR)) were also present but not equally enriched in the PM fraction, in agreement with the presence of large pools of these receptors on endosomal membranes. The endosomal marker protein (EEA1) was greatly depleted, and the Golgi marker protein GM130 was absent, whereas small amounts of ER proteins recovered in the PM, such as calreticulin, VAPA, VAPB and STIM1, most likely reflect tightly attached cortical ER ( Fig. 4f,g) . Importantly, the recovery of endogenous E-Syt1 and E-Syt2 on bead-attached PM sheets was similar to that of other integral ER proteins (calreticulin, VAP and STIM1; Fig. 4g ), further supporting their localization in the ER 8 . The similar subcellular recovery of endogenous E-Syt1 and E-Syt2 in the bead-bound material confirms that these two proteins are primarily present in cells as heterodimers localized throughout the ER, with only a small fraction of the heterodimer being already at ER-PM contact sites in control conditions 8 .
Analysis by mass spectrometry of the major glycerolipid species in the PM fractions of WT and E-Syt KO cells did not reveal specific changes compared to total cellular lipids (individual extracts from DKO and TKO cells were independently analysed and then pooled as they had similar properties in all functional assays consistent with the very low abundance of E-Syt3 in HeLa cells 8 ; Fig. 4h ), thus speaking against a major role of the E-Syts in controlling the steady-state distribution of these lipids in the PM.
Sustained accumulation of diacylglycerol at the PM following activation of PLC in E-Syt KO cells
The E-Syts may play a role in homeostatic responses to conditions that acutely affect the lipid compositions of the PM. Transient increase in E-Syt1-dependent ER-PM tethers in response to activation of PLC-coupled receptors may be part of a mechanism to counteract PtdIns(4,5)P 2 loss in response to its hydrolysis. However, TIRF microscopy analysis of the PtdIns(4,5)P 2 probe mRFP-PH-PLCδ to monitor PtdIns(4,5)P 2 depletion and resynthesis at the PM in response to Oxo-M-induced PLC activation of overexpressed M1R did not reveal obvious defects in the absence of the E-Syts at any time point ( Supplementary Fig. 4a ). These findings speak against a major role of these proteins in the regulation of PtdIns(4,5)P 2 dynamics.
Another potential function of E-Syts in response to PLC activation is the control of the dynamics of diacylglycerol (DAG) generated by PtdIns(4,5)P 2 cleavage. Levels of PM DAG are very low at rest ( Fig. 4h ), transiently increase on PLC activation and then gradually return to normal levels 26 . TIRF microscopy of the fluorescence signal of C1-mCherry (mCherry-C1 domains of PKCδ) 30 , a DAG probe, showed that the increase of this lipid in the PM on stimulation of endogenous PLC-coupled histamine receptor was more sustained in the absence of the E-Syts. Importantly, the expression of EGFP-E-Syt1 together with Myc-E-Syt2 rescued the phenotype (Fig. 5a ). Although the increase of DAG occurs at the expense of PtdIns(4,5)P 2 cleavage, under these conditions (endogenous histamine receptor levels) only modest PtdIns(4,5)P 2 hydrolysis was observed ( Supplementary Fig. 4b ). Thus, a basal pool of E-Syts could still bind to the PM ( Supplementary  Fig. 4b ) in contrast to what happens on Oxo-M stimulation of M1R-overexpressing cells, when PtdIns(4,5)P 2 was rapidly depleted ( Supplementary Fig. 4c ), leading to rapid and massive dissociation of the E-Syts from the PM.
We also tested the effect of ionomycin, whose stimulation of Ca 2+ influx also results in massive, but somewhat delayed, PLC-dependent hydrolysis of PtdIns(4,5)P 2 (ref. 31 ) so that E-Syt1 is recruited at the PM before complete PtdIns(4,5)P 2 depletion (see Fig. 5b for the recruitment of endogenously tagged E-Syt1, endoEGFP-E-Syt1). A very robust recruitment of C1-mCherry to the PM of these cells was observed in response to ionomycin ( Fig. 5b ,c), as detected by TIRF microscopy. Even with this drug, the accumulation of DAG (C1-mCherry fluorescence) in cells lacking E-Syts was more sustained in time relative to WT cells. Re-expression of either EGFP-E-Syt1 together with Myc-E-Syt2 ( Fig. 5c,d) or EGFP-E-Syt1 alone (Fig. 5e ) rescued the phenotype, but a mutant EGFP-E-Syt1 lacking the SMP domain did not ( Fig. 5e ), supporting a role for E-Syt1 in the regulation of DAG dynamics through an SMP-dependent mechanism. Prolonged accumulation of DAG on activation of PLC in E-Syt KO cells was further confirmed by another DAG probe, YFP-DBD (YFP fused to the C1b domain of PKCβII) 32 ( Supplementary Fig. 5a ).
Ca 2+ -dependent DAG transfer by E-Syt1 in vitro
The cell-free assay shown in Fig. 2 demonstrates that E-Syt1 can transfer a glycerolipid, and thus, most likely also DAG. However, the ability of E-Syt1 to mediate Ca 2+ -stimulated DAG transfer was directly assessed. As DAG does not have a headgroup that can be labelled with NBD, a radioactivity-based in vitro assay was used. 'Heavy' (sucrose loaded) liposomes composed of PC, VAPB PS, PtdIns(4,5)P 2 and supplemented with 3 H-DAG were mixed in the presence or absence of 100 µM Ca 2+ with 'light' (no sucrose) liposomes composed of PC and DGS-NTA(Ni) and with either the purified His-tagged E-Syt1 cyto or E-Syt1 cyto lacking the SMP domain (E-Syt1 cyto ∆SMP) ( Fig. 6a , and see Methods). Subsequently, E-Syt1-tethered donor and acceptor liposomes were separated by the addition of a cocktail of imidazole and proteinase K followed by centrifugation ( Fig. 6b ). Analysis of radioactivity in the two populations of liposomes revealed robust SMP-domain-dependent and Ca 2+ -stimulated 3 H-DAG accumulation in light liposomes, proving the ability of E-Syt1 to transport DAG (Fig. 6c ).
Ca 2+ -dependent recruitment of E-Syt1 in KO cells extracts DAG from the PM
A mechanism accounting for the clearance of excess DAG from the PM is its conversion to PA by DAG kinases (DGK) 33 . The lipid transport protein Nir2 is recruited to ER-PM contacts in a DAG-and phosphatidic acid (PA)-dependent manner following PLC-dependent values are plotted as the percentage of 3 H radioactivity in the supernatant (that is, light acceptor liposomes) over the sum of the total radioactivity in the supernatant and pellet (that is, light and heavy donor liposomes). Right: normalized Ca 2+ -dependence of E-Syt1-mediated DAG transfer was plotted after background subtraction (mean ± s.e.m., n = 3 independent experiments for all of the conditions; two-tailed Student's t-test with equal variance, * * P < 0.0001).
PtdIns(4,5)P 2 hydrolysis and transfers PA to the ER for metabolic recycling 34, 35 (Fig. 7a ). E-Syt-and Nir2-dependent mechanisms may cooperate in the recycling of these PtdIns(4,5)P 2 metabolites. To assess the interplay of E-Syts with Nir2 in the clearance of DAG, we inhibited its conversion to PA using the DGK inhibitor DGKi during the recovery phase from an Oxo-M-dependent stimulus in M1R-expressing cells. As assessed by TIRF microscopy, Oxo-Mtriggered PLC activity resulted in a rapid rise of DAG, which was reversed by the M1R antagonist atropine (Fig. 7b ). The rate of DAG removal during atropine treatment, that is, when Ca 2+ levels have returned to normal 27 , was not substantially affected by the absence of the E-Syts ( Supplementary Fig. 6a ). Addition of DGKi together with atropine, blocked the gradual DAG loss, as expected ( Fig. 7c ). However, addition of ionomycin 2.5 min following atropine/DGKi application to HeLa cells expressing E-Syt1 EGFP-tagged at the endogenous locus triggered robust recruitment of endoEGFP-E-Syt1 to the PM and rapid loss of the DAG reporter C1-mCherry ( Fig. 7d ). Both DAG removal and E-Syt1 recruitment required the presence of extracellular Ca 2+ ( Supplementary Fig. 6b ). Importantly, in cells lacking E-Syts (TKO cells), ionomycin did not produce a loss of DAG signal in the PM and re-expression of EGFP-E-Syt1 alone, but not of E-Syt1 lacking the SMP domain (Fig. 7e ,f) or its ER anchor 8 ( Supplementary Fig. 6c ), was sufficient to rescue the phenotype. Mutations of the hydrophobic pockets of the SMP domain (see above) also significantly reduced rescuing activity (Fig. 7e,f) .
These results support a role for E-Syt1 in exchanging lipids between the PM and the ER and the presence of a pathway that acts in parallel to Nir2 for the clearance of PtdIns(4,5)P 2 metabolites (Fig. 7a ). However, further analyses suggested that the PM recruitments of Nir2 and of E-Syt1 can be decoupled. Simultaneous imaging of Nir2-mCherry and endoEGFP-E-Syt1 showed that Nir2 is rapidly recruited to the PM on triggered massive Oxo-M-triggered PLC-dependent PtdIns(4,5)P 2 cleavage as reported previously 34, 36, 37 (Fig. 7g ). This rise occurred even when the E-Syts dissociated from the PM owing to PtdIns(4,5)P 2 depletion after a very transient Ca 2+ -dependent recruitment before the drop of PtdIns(4,5)P 2 . Conversely, during PtdIns(4,5)P 2 recovery on atropine treatment, Nir2 dissociated from the PM whereas E-Syt1 (that is, primarily reflecting the E-Syt1/E-Syt2 heterodimer in these experiments where tagged E-Syt1 was expressed at endogenous levels) returned to its basal levels at this membrane. Furthermore, the additional very robust recruitment of E-Syt1 triggered by ionomycin did not have an effect on Nir2 ( Fig. 7g and Supplementary Video 3) . Nir2 and E-Syt1 recruitment occurred at the same ER-PM contact sites (see kymographs in Fig. 7g ), suggesting the pre-existence of contacts that are populated by different lipid transfer proteins depending on the functional state of the cell.
Finally and importantly, robust recruitment of Nir2 to the PM was observed in cells lacking E-Syts following ionomycin treatment, but not in control cells (Fig. 7h-j) , indicating a strong functional connection between the functions of the two proteins ( Fig. 7h-j) . As recruitment of Nir2 to the PM is thought to be dependent, at least in part, on DAG and PA presence in this membrane, these findings further support a role of the E-Syts in clearing PtdIns(4,5)P 2 lipid metabolites from the PM.
Together, these results reveal the occurrence of an E-Syt-dependent pathway for the removal of excess DAG from the PM following PLC activation, which is likely to act in cooperation with the pathway involving conversion to PA and Nir2 (refs 33,34) .
DISCUSSION
Our present results provide direct evidence for the suggested ability of the E-Syts to transfer lipids between bilayers and demonstrate the impact of the E-Syts on the regulation of lipid homeostasis in the PM. They further show the importance of the Ca 2+ -dependent regulation of E-Syt1 in its lipid transfer function.
The ability of E-Syt1 to transport lipids was proved by in vitro lipid transfer between liposomes mimicking the ER (no acidic phospholipids) and the PM (presence of PtdIns(4,5)P 2 and PS) respectively. In these assays, the entire cytosolic domain of E-Syt1 was anchored to the ER-like liposomes via a histidine tag, and addition of Ca 2+ led to its interaction in trans with PM-like liposomes to allow lipid transfer. Transfer was bidirectional, dependent on the lipidharbouring properties of the SMP domain and on the presence of PtdIns(4,5)P 2 in the PM-like liposomes. Moreover, transfer was driven by the concentration gradient of the lipid and strongly potentiated by the presence of Ca 2+ in the micromolar range, consistent with recent results describing the Ca 2+ -dependency of E-Syt1 recruitment to the PM in semi-intact cells 12 . A major role of Ca 2+ in lipid transfer is to promote the membrane tethering function of E-Syt1, which requires the Ca 2+ -binding properties of its C2C domain 8, 11, 12, 37 . However, it is also possible that Ca 2+ -dependent binding to lipid bilayers of its C2A domain, which also contains a Ca 2+ -binding site 8, 13, 36 , may assist lipid transfer by a direct and local effect on the bilayer. As a Ca 2+sensitive C2A domain is present in E-Syt2 and E-Syt3 13 , even these two proteins, whose ER to PM tethering function is not regulated by Ca 2+ , may in fact have a Ca 2+ -dependent role in lipid transfer. This hypothesis deserves further investigation. Collectively, in vitro studies demonstrate that the E-Syts facilitate passive transport of glycerolipids between bilayers along concentration gradients.
As we show here, the E-Syts are not essential for cellular life. Cells that lack expression of all three E-Syts do not exhibit major obvious defects, although they grow more slowly than controls. This lack of major defects may be explained by overlapping functions with other SMP-domain-containing proteins in mammalian cells 19 . However, yeast cells that lack all three tricalbins, which seem to be the only SMP-domain-containing homologues of E-Syts in this organism, are also viable, suggesting that the function of this protein family is not essential 10 . Accordingly, mass spectrometry analysis of PM isolated from WT and E-Syt KO cells using a one-step procedure, did not reveal a difference in the composition of the PM in the major glycerolipid species. Our study suggests that one of E-Syts' functions is to help produce adaptive changes in the PM following an acute perturbation. In cells lacking expression of all E-Syts, impaired disappearance from the cytosolic leaflet of the PM of newly generated DAG on PLC activation was observed. E-Syt1 alone could rescue the defect and rescue depended on the lipid-harbouring property of its SMP domain and required its anchorage to the ER.
Another mechanism responsible for the rapid return to basal levels of DAG after its acute generation by PLC-dependent PtdIns(4,5)P 2 cleavage is its conversion to PA in the PM, followed by PA transfer to the ER 35 at least in part via the lipid transfer protein Nir2 (and possibly also by Nir3) 34 . As the E-Syts can harbour glycerophospholipids irrespective of the headgroup, cooperation of E-Syts with Nir2 in PA transport is plausible. Like E-Syts, Nir2 is recruited to ER-PM contacts in response to PLC activation 34, 37 . Our results show the recruitment of Nir2 and E-Syt1 to the PM, and thus their functions, can be decoupled. However, Nir2 and the E-Syts are functionally linked, as ionomycin stimulation induces a robust and prolonged accumulation of Nir2 at the PM in cells that lack all three E-Syts but not in control cells.
If the E-Syts can transfer promiscuously glycerolipids (and possibly other lipids), one may wonder why they do not reduce the difference in glycerolipid composition between the ER and the PM. One explanation is that their equilibrating action is continuously conteracted by mechanisms that generate diversity. Another explanation, given the Ca 2+ dependence of their transport, is that restoring normal lipid levels in response to acute perturbations, as shown here for PM-localized DAG, may in fact be their major functions.
In summary, our study demonstrates a role for the ER-localized E-Syts in the regulation of PM lipid homeostasis via in trans actions at ER-PM contact sites. Our findings emphasize a role for these proteins in maintaining lipid homeostasis in response to acute perturbations. However, additional functions of these proteins are plausible. Studies in yeast and plants have pointed to increased PM fragility in cells lacking tricalbins/extended synaptotagmins 17, [38] [39] [40] . The potential occurrence of other changes in the PM bilayers of E-Syt TKO cells deserves further investigation. Further elucidating the physiological roles of these proteins as well as of other SMPdomain-containing proteins localized at membrane contact sites will be important to gain insight into how non-vesicular transport of lipids between bilayers contributes to maintain the specific lipid composition of each membrane.
METHODS

Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb3339 METHODS Antibodies and chemicals. The primary and secondary antibodies used in this study are listed in Supplementary Table 1 . Oxo-M, atropine and ionomycin (Sigma-Aldrich); thapsigargin (Invitrogen/Life Technologies); DGK inhibitor (R 59-022, Tocris Bioscience); proteinase K (Sigma-Aldrich). The following concentrations of chemicals are used in all of the experiments unless noted otherwise: Oxo-M, 10 µM; atropine, 50 µM; ionomycin, 2 µM; thapsigargin, 2 µM; DGK inhibitor, 50 µM. All non-radiolabelled lipids were obtained from Avanti Polar Lipids: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 850457; 1,2dioleoyl-sn-glycero-3-phosphoserine (DOPS), 840035; L-α-phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P 2 ), 840046; (NBD)-1,2-dipalmitoyl-sn-glycero-3phosphoethanolamine (DPPE), 810144; 1,2-dioleoyl-sn-glycero-3-[(N -(5-amino-1-carboxypentyl) iminodiacetic acid) succinyl] (DGS-NTA(Ni)), 790404; 1-2dioleoyl-sn-glycerol (DAG), 800811. Radiolabelled lipids were purchased from American Radiolabelled Chemicals: 1,2-dioleoyl [9,10-3H] rac-glycerol, ART 2185.
Plasmids. Untagged E-Syt1, Myc-E-Syt2 (corresponding to the previously described Myc-E-Syt2S'' 8 ), EGFP-E-Syt1, iRFP-PH-PLCδ1 and mRFP-PH-PLCδ1 were previously described 8, 41 . The following reagents were kind gifts: mRFP-Sec61β from T. Rapoport (Harvard University, USA) 42 , M1 muscarinic acetylcholine receptor (M1R) from B. Hille (University of Washington, USA) 28 , ER-oxGFP from E. L. Snapp (Albert Einstein College of Medicine, USA), Nir2-mCherry from R. Dong (Yale University, USA). YFP-DBD and C1-EGFP from Addgene (plasmid no. 14874 and no. 21216) 30 . The sequences of primers used in this study are listed in Supplementary Table 2 .
Cloning of EGFP-E-Syt1∆SMP. EGFP-E-Syt1∆SMP was generated by site-directed mutagenesis (QuickChange II-XL, Stratagene) using the primers E-Syt1_SdeI_F and E-Syt1_Sdel_R in EGFP-E-Syt1.
Cloning of EGFP-E-Syt1 V169W + L308W. Two hydrophobic amino acid residues (L308W and V169W) within the hydrophobic groove of the SMP domain were mutated to tryptophan using site-directed mutagenesis in EGFP-E-Syt1 using the primer sets E-Syt1_L308W_MF, E-Syt1_L308W_MR, E-Syt1_V169W_MF and E-Syt1_V169W_MR.
Cloning of GST-E-Syt1 SMP-C2A-C2B and GST-E-Syt1 SMP-C2A-C2B V169W+L308W. gBlock (IDT) containing E-Syt1 cDNA carrying V169W+L308W mutations was synthesized and amplified by PCR using the primer set 5 E1_SMP_EcoRI and 3 E1_SMP_EcoRI.
PCR products were ligated in the EcoRI site in the pDF6 vector containing E-Syt1 cDNA to generate GST-E-Syt1 SMP+C2A+C2B V169W+L308W. Cloning of C1-mCherry. cDNA corresponding to C1 domains of C1-EGFP was excised and ligated into mCherry-N1 vector in the KpnI site. The vector was digested with BamHI and the 5 overhang was filled by DNA Polymerase I, Large (Klenow) Fragment (NEB) to make C1 domains in-frame to mCherry.
Cell culture and transfection. HeLa cells were purchased from ATCC. They were cultured in Dulbecco's modified essential Eagle medium (DMEM; Life Technologies) supplemented with 20% (v/v) fetal bovine serum (FBS) at 37 • C and 5% CO 2 . Transfection of plasmids was carried out with Lipofectamine 2000 (Life Technologies) according to the manufacturer's instructions. RNAi against endogenous E-Syt1 was carried out as described in ref. 8 . Wild-type as well as genome-edited HeLa cell lines were verified as free of mycoplasma contamination by a PCR-based method. No cell lines used in this study were found in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample. All cell-based experiments were repeated at least two times.
Generation of anti-E-Syt1 antibodies. A peptide consisting of the N-terminal 19
amino acids of E-Syt1 (ERSPGEGPSPSPMDQPSAP) and an additional carboxyterminal cysteine was synthesized by GenScript. Keyhole limpet haemocyanin (KLH) was conjugated to the cysteine residue and rabbits were immunized with the peptide. Serum was collected and polyclonal antibodies were affinity purified on the peptide used for immunization with SulfoLink Immobilization Kit for Proteins (Thermo Scientific). To further reduce nonspecific reactivity in immunofluorescence labelling of aldehyde fixed cells, the affinity-purified anti-E-Syt1 antibodies were incubated with aldehyde-fixed lysates of E-Syt1/2 DKO cells. Briefly, E-Syt1/2 DKO cells were fixed with 4% PFA in PBS at room temperature for 20 min, incubated with PBS containing 50 mM glycine at room temperature for 10 min and scraped in PBS containing 1% BSA and 0.1% Triton X-100. Affinity-purified antibodies were added to the resulting suspension and incubated at 4 • C overnight. This material was then centrifuged at 21,000g for 20 min at 4 • C to pellet fixed cell debris, and the supernatant was used for immunofluorescence.
Fluorescence microscopy. For imaging experiments, cells were plated on 35-mm glass-bottom dishes at low density (MatTek). Immunofluorescence and live cell
imaging were carried out one day after transfection. Spinning-disc confocal (SDC) microscopy was performed using the Improvision UltraVIEW VoX system (Perkin-Elmer) built around a Nikon Ti-E inverted microscope, equipped with PlanApo objectives (40 × 1.0-NA and 60×1.49-NA) and controlled by Volocity (Improvision) software. Excitation light was provided by a 488-nm/50-mW diode laser (Coherent) and a 561-nm/50-mW diode laser (Cobolt), and fluorescence was detected by an EM-CCD (electron-multiplying charge-coupled device) camera (C9100-50; Hamamatsu Photonics).
Total internal reflection fluorescence (TIRF) microscopy was performed on a setup built around a Nikon Ti-E microscope equipped with 60×1.49-NA. Excitation light was provided by 488-nm (for GFP), 561-nm (for mCherry/mRFP/mdsRed) and 640-nm (for iRFP) DPSS lasers coupled to the TIRF illuminator through an optical fibre. The output from the lasers was controlled by an acousto-optic tunable filter and fluorescence was detected with an EM-CCD camera (Andor iXon DU-897). Acquisition was controlled by Andor iQ software. Images were sampled at 0.20 Hz with exposure times in the 100-500 ms range. SDC microscopy was carried out at room temperature (20-25 • C) and TIRF microscopy at 37 • C.
Immunofluorescence. HeLa cells transfected with mRFP-Sec61β were washed twice with PBS and fixed with 4% PFA in PBS at room temperature for 20 min, washed with PBS and incubated with PBS containing 50 mM glycine at room temperature for 10 min. Fixed cells were permeabilized with PBS containing 1% BSA and 0.1% Triton X-100 (blocking buffer) and incubated with primary antibodies for one hour at room temperature. Cells were then washed with blocking buffer twice and incubated with Alexa Fluor 488-conjugated anti-rabbit secondary antibodies for one hour at room temperature. After 4× washing with PBS, cells were examined under a SDC microscope. Images from a mid-focal plane are shown.
Live cell imaging. Cells were washed twice and incubated with either Ca 2+ -containing buffer (140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 10 mM HEPES, 10 mM glucose, and 2 mM CaCl 2 (pH 7.4)) or Ca 2+ -free buffer (140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 10 mM HEPES, 10 mM glucose, and 3 mM EGTA (pH 7.4)) before imaging with either a SDC microscope or a TIRF microscope. Electron microscopy. Cells attached to Cytodex 3 microcarrier beads (Sigma-Aldrich) were fixed in 2% glutaraldehyde-0.1 M sodium cacodylate buffer at pH 7.4. Cells were post-fixed with 1% OsO 4 in 1.5% K 4 Fe(CN) 6 -0.1 M sodium cacodylate buffer, followed by en bloc staining with 2% uranyl acetate in 50 mM sodium maleate buffer at pH 5.2, dehydration and embedding in Embed 812. Electron microscopy reagents were purchased from Electron Microscopy Sciences.
Biochemical analyses. Plasma membrane isolation and protein extraction. The procedure was modified from ref. 29 . Briefly, 2g of Cytodex 3 microcarrier beads (Sigma-Aldrich) were reconstituted in 100 ml PBS, autoclaved and coated by incubation with a poly-D-lysine solution overnight at 37 • C. Cells were added to the reconstituted beads in sterile PETG flasks (Thermo Scientific), allowed to attach to the beads for 4 h with gentle stirring every 30 min and then further incubated overnight with continuous stirring on a rotating incubator at 37 • C with 5% CO 2 . Beads were subsequently collected by spontaneous sedimentation and incubated with 220 mM sucrose, 40 mM sodium acetate, at pH 5.0 for 5 min at room temperature. This step was necessary to maximize the area of plasma membrane adherent to the beads 29 . After the acid treatment, beads were collected, incubated with a hypotonic solution (10 mM Tris-HCl, pH 8.0) and vortexed for 10 s. A 10 s sonication pulse was then applied to the beads with Virsonic 550 (Virtis) in the same solution. Beads were finally washed three times again with the same solution and either once with PBS for subsequent protein extraction with SDS lysis buffer (10 mM Tris-HCl, 150 mM NaCl, 2% SDS, pH 8.0) or with 150 mM ammonium bicarbonate for lipidomic analysis.
Lipidomics. Lipid extraction, mass spectrometric analysis and data analysis were done by Lipotype GmbH (Germany). Briefly, lipids were extracted from either total cells still attached to the beads (total lipids), or from bead-bound PMs prepared as described above (PM lipids) using chloroform and methanol 43 . Samples were spiked with lipid class-specific internal standards before extraction and lipid extracts were immediately subjected to mass spectrometric analysis. Mass spectra were acquired on a hybrid quadrupole/Orbitrap mass spectrometer (Q-Exactive, Thermo-Fisher) equipped with an automated nano-flow electrospray ion source (Triversa Nanomate, Advion) in both positive and negative ion mode. Lipid identification using Lipotype Xplorer was performed as previously described 44 .
Lipid binding to purified E-Syt1. GST-tagged E-Syt1 fragments containing the SMP domain and C2A and C2B domains (predicted molecular weight: 53.6 kDa) were generated and purified using a bacterial expression system and tested for in vitro lipid-binding assay as described previously 22 .
Western blotting and immunoprecipitation. HeLa cells were lysed in SDS lysis buffer (10 mM Tris-HCl, 150 mM NaCl, 2% SDS, pH 8.0). Cell lysates were incubated at 60 • C for 20 min followed by incubation at 70 • C for 10 min. Benzonase nuclease (Novagen) was added, and the samples were further incubated at room temperature for 20 min. Cell lysates were loaded and separated in 8% or 4-20% SDS-PAGE gels and immunoblotting was carried out as described previously 8 . Immunoprecipitation of endogenously tagged EGFP-E-Syt1 (Fig. 1e) , overexpressed EGFP-E-Syt2 (Fig. 3b) and EGFP-E-Syt1 ( Supplementary Fig. 3f ) was carried out using GFP-Trap beads as previously described 8 .
Liposome-based experiments. Cloning, expression and purification of an E-Syt1 fragment. The region coding for residues 93-1104 of human E-Syt1 was cloned into the pCMV6-AN-His vector with an N-terminal His 6 -tag. The protein was expressed in Expi293 cells for three days. Cells were collected and lysed by three freeze-thaw cycles (liquid N 2 and 37 • C water bath) in buffer (25 mM Tris-HCl, pH 8.0, 300 mM NaCl, 10 mM imidazole, 0.5 mM TCEP) supplemented with protease inhibitors (Complete EDTA-free; Roche). The protein was purified from the cell lysate by a Ni-NTA column (Clontech), and then further purified by gel filtration (Superdex 200, GE Healthcare) in buffer (25 mM Tris-HCl, pH 8.0, 300 mM NaCl, 0.5 mM TCEP).
Fractions containing E-Syt1 were pooled and concentrated to ∼1 mg ml −1 .
Liposome preparation. Lipids in chloroform were dried under a stream of N 2 gas followed by further drying in vacuum for 2 h. Mole percent values of lipids used for the acceptor and donor liposomes in fluorescence resonance energy transfer (FRET)based lipid transfer experiments were as indicated in Supplementary Table 3 .
The dried lipid films were hydrated with buffer (25 mM Tris-HCl, pH 8.0, 300 mM NaCl, 0.5 mM TCEP). Liposomes were then formed by ten freeze-thaw cycles (liquid N 2 and 37 • C water bath) followed by extrusion through polycarbonate filters with a pore size of 50 nm (Avanti Polar Lipids).
Dequenching (loss of self-quenching) efficiency assays. Dequenching assays of NBD were performed in 50 µl volumes containing 0.5 mM total lipids (50 µM donor liposomes containing either 1%, 3%, 5% or 7% fluorescent lipids plus 450 µM acceptor liposomes). NBD was excited at 460 nm. Self-quenching was determined by recording emission intensity at 538 nm with or without 0.5% n-dodecyl-ß-D-maltoside (DDM). Experiments were carried out at room temperature on a SpectraMax M5 Microplate Reader (Molecular Devices).
FRET-based lipid transfer assays. Lipid transfer reactions were performed in 50 µl volumes. The final lipid concentration in the reaction was 0.5 mM, with donor and acceptor liposomes added at a 1:9 ratio (or 1:1 for Supplementary Fig. 2e ). Reactions were initiated by the addition of protein to a final concentration of 0.5 µM in a 96-well plate (Corning). The fluorescence intensity of NBD was monitored with an excitation of 460 nm and emission of 538 nm every 10 s over 30 min at room temperature by using a SpectraMax M5 Microplate Reader (Molecular Devices). All data were corrected by setting the value at the time of protein addition to zero, and subtracting the baseline values obtained in the absence of the protein. The data were expressed as a percentage of the maximum fluorescence, determined after adding 10 µl of 2.5% DDM to the reactions after 30 min.
Liposome tethering assays. Liposome tethering assays were performed as for lipid transfer assays, except that the absorbance at 405 nm was measured every 10 s over 40 min at room temperature by using a SpectraMax M5 Microplate Reader (Molecular Devices). Ten microlitres of cocktail (1.8 M imidazole, 15 mM EGTA, 1.15 mg ml −1 proteinase K) was added to stop the reaction after 30 min. The absorbance before protein addition was set to zero.
Content mixing assays. For content mixing assays, donor liposomes (85:15 mole percent POPC: DGS-NTA Ni ) and acceptor liposomes (85:10:5 mole percent POPC: DOPS: PtdIns(4,5)P 2 ) were formed as for lipid transfer assays, except that 50 mM sulforhodamine B (Sigma-Aldrich) was included during the hydration of donor liposomes. The donor liposomes were pelleted in a Beckman TLA-100 rotor for 10 min at 55,000 r.p.m. (20 • C) to remove unencapsulated sulforhodamine B and the pellets were resuspended in buffer (25 mM Tris-HCl, pH 8.0, 300 mM NaCl, 0.5 mM TCEP). The reactions were performed as for lipid transfer assays, except that the fluorescence intensity of sulforhodamine B was monitored with an excitation of 565 nm and emission of 585 nm.
Radiolabelled lipid transfer assays. 'Heavy' donor and 'light' acceptor liposomes were as follows. 'Heavy' liposomes: 300 µmol lipids (84:10:5:0.9:0.1 mole percent POPC: DOPS: PtdIns(4,5)P 2 : DAG: tritium-labelled DAG for donor liposomes) in chloroform were dried in the vacuum for 1.5 h. The lipid films were hydrated with buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5 mM TCEP, 0.75M sucrose) and incubated at 37 • C for 30 min. Liposomes were then formed by five freeze-thaw cycles (liquid N 2 and 37 • C incubation), pelleted and resuspended in buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5 mM TCEP). 'Light liposomes' were composed of 85% POPC and 15% DGS-NTA(Ni) and were prepared as for FRET-based lipid transfer assays.
Lipid transfer reactions were performed in 100 µl volumes. The final lipid concentration in the reaction was 0.5 mM, with 'heavy' donor and 'light' acceptor liposomes added at a 1:2 ratio. Reactions were initiated by the addition of protein to a final concentration of 0.5 µM and terminated by the addition of 10 µl of a solution containing 1.8 M imidazole and 1.15 mg ml −1 proteinase K. 'Heavy' and 'light' liposomes were then separated by centrifugation at 16,000g for 15 min and 'heavy' liposomes recovered in the pellets were resuspended in 100 µl buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5 mM TCEP). Radioactivity present in the supernatant and in the resuspended pellets was then determined at room temperature with a Liquid Scintillation Counter 1409DSA (Wallac).
CRISPR/Cas9-mediated endogenous tagging of E-Syt1
. This procedure was performed by PNAbio. Briefly, the donor vector comprising cDNA encoding EGFP with a linker sequence (SGLRSRAQASNSAVD) flanked by ∼500 bp homologous recombination arms covering the 5 end of exon1 of human E-Syt1 gene was synthesized and co-transfected in HeLa cells with the guide RNA (RG6: AATGGAGCGATCTCCAGGAGAGG) and Cas9. EGFP-positive cells were FACS enriched and individual cells were isolated. PCR-based genotyping of ∼150 clones identified several candidate clones with genomic integration of the donor sequence at the endogenous E-Syt1 locus. These clones were further analysed by PCR-based genotyping, sequencing and western blotting. The endogenously tagged cells were further characterized by RNAi and microscopy as shown in the results.
Generation of E-Syt knockout HeLa cell lines.
A transcription activator-like effector nuclease (TALEN) pair that targets the region encoding the SMP domain of human E-Syt2 and two CRISPR guide RNAs, E-Syt1(6) and E-Syt1 (7) , that target the region encoding the hydrophobic hairpin stretch of human E-Syt1 were designed (Fig. 3a) . The efficiencies of the TALEN pair and CRISPR/Cas9 were estimated as 10.9%, 2.5% and 4.5% respectively using a Surveyor nuclease assay ( Supplementary Fig. 3a ). To enrich genome-edited cells that carry insertions or deletions (indels) at the targeted loci, the surrogate vector system 45 and fluorescence activated cell sorting (FACS) were used to enrich for cells expressing the EGFP encoded by the surrogate vector. In brief, the inserted target sequences for TALEN or Cas9 are flanked by mCherry and EGFP. Without non-homologous end joining (NHEJ)-mediated repair of DNA double-stranded breaks, the stop codon (shown in red) allows only mCherry expression. After NHEJ, frame-shift in the target sequence leads to expression of mCherry-EGFP fusion protein, resulting in an increase in EGFP signals ( Supplementary  Fig. 3b,c) . First, KO HeLa cells for E-Syt2 were generated. The E-Syt1 and E-Syt3 genes were subsequently targeted in these cells by CRISPR/Cas9.
For the generation of HeLa cells lacking E-Syt2, WT cells were transfected with the plasmids encoding the E-Syt2-targeting TALEN pair and the surrogate vector, followed by enrichment of genome-edited cells via FACS and isolation of individual clones by dilution cloning. PCR analysis of the genomic DNA isolated from 39 individual clones verified candidate indels in the region encoding the SMP domain of E-Syt2 ( Supplementary Fig. 3d ). Two clones (line 10 and line 38) were further characterized with sequencing and western blotting. These analyses revealed predicted deletions within the TALEN pair-binding sites, frame-shift and early termination in the open-reading frame of the E-Syt2 gene, and the loss of E-Syt2 protein expression ( Supplementary Fig. 3e,f) . To generate E-Syt1/2 DKO cell lines, a subclone of E-Syt2 knockout cell line 38 was transfected with plasmids encoding hCas9, E-Syt1 specific guide RNA expression vectors (E-Syt1 (6) or E-Syt1 (7) ) and the surrogate vector, followed by FACS-mediated enrichment of fluorescent cells (see above; Supplementary Fig. 3b,c) . Individually isolated clones, line 6-8 and line 7-5 (hereafter E-Syt1/2 DKO:6-8 and E-Syt1/2 DKO:7-5; in all figures and text, E-Syt1/2 DKO denotes E-Syt1/2 DKO:6-8 unless stated otherwise), showed insertion of one nucleotide within the guide RNA-targeted loci, resulting in a lack of E-Syt1 protein expression ( Fig. 3b and Supplementary Fig. 3g ). Immunostaining of E-Syt1/2 DKO cells with the newly generated anti-E-Syt1 antibody (see above) confirmed the absence of E-Syt1 signals in these cell lines ( Supplementary Fig. 1b ).
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To generate E-Syt triple-knockout (TKO) cell lines, the E-Syt1/2 DKO:6-8 cell line was transfected with a plasmid encoding hCas9 and four PCR-amplified guide RNAs targeting the 5 region of E-Syt3 (Fig. 3a) . The surveyor nuclease assay showed robust cutting efficiency (∼28%), allowing isolation of knockout cells without further enrichment (Fig. 3b ). Three clones that showed large indels in exon1 of E-Syt3 by sequencing were isolated and the absence of E-Syt3 protein was confirmed by IP-enrichment followed by western blotting (Fig. 3b ).
Construction of TALEN, CRISPR and surrogate vectors.
TALEN for E-Syt2 knockout. A TALEN pair targeting human E-Syt2 was assembled using the Golden-Gate ligation method as described previously 46 .
Target sequence, RVDs and vector used were: TALEN-SMP_L: TGTAAAACAC ATGTGGCCTT, (NG) NN NG NI NI NI NI -HD NI HD NI NG NN -NG NN NN HD HD NG (NG), pTALEN_v2(NG); TALEN-SMP_R: TAGTTTCTCGAAACAACTTC, (NG) NI NN NG NG NG HD -NG HD NN NI NI NI -HD NI NI HD NG NG (HD), pTALEN_v2(HD).
Surrogate vector was designed following the strategy previously published 45 . To generate a surrogate vector for the TALEN-SMP pair, the DNA oligonucleotide TALEN was synthesized and used as a template for PCR reaction.
Primers used were 5 BglII_SMP-1 Surro and 3 BamHI_SMP-1 Surro. PCR products were ligated between BglII and BamHI in mCherry-E-Syt2-EGFP 8 to generate mCherry-SMP-1 Surro-EGFP.
PCR genotyping was carried out using the primer set 5 SMP-1 N and 3 SMP-1 Ex, which generates a 311 bp fragment in control.
TALEN-SMP_L, TALEN-SMP_R and mCherry-SMP-1 Surro-EGFP were cotransfected in HeLa cells, and EGFP-positive cells were sorted with the iCyt SY3200 (Sony) 72 h after transfection. Sorted cells were individually cloned by dilution cloning and assessed by genotyping PCR and western blotting. The sequences of oligonucleotides and primers used are listed in Supplementary Table 2 .
CRISPR/Cas9 for E-Syt1 knockout and E-Syt3 knockout. E-Syt1 knockout: gBlock (IDT) comprising U6 promoter, human E-Syt1 target sequence and guide RNA was synthesized as described previously 47 . gBlock was incubated with Taq polymerase and ligated into pCR2.1 TOPO vector using the TOPO-TA cloning kit (Life Technologies); target sequences used were E-Syt1 (6) and E-Syt1 (7) .
To generate a surrogate vector for the CRISPR/Ca9 targeting E-Syt1, DNA oligonucleotides E-Syt1(6,7)_F and E-Syt1(6,7)_R were synthesized, phosphorylated using T4 PNK and annealed.
Products were ligated between BglII and BamHI in mCherry-E-Syt2-EGFP 8 to generate mCherry-E-Syt1(6,7)-EGFP.
PCR genotyping was carried out using the following primer set: 5 ESYT1_TM_F2 and 3 ESYT1_TM_R2, which generates a 489 bp fragment in the control.
Either TOPO CRISPR E-Syt1 (6) or TOPO CRISPR E-Syt1(7) together with hCas9 47 and mCherry-E-Syt1(6,7)-EGFP was co-transfected in E-Syt2 KO (line 38 described above) HeLa cells, and EGFP-positive cells were sorted with the iCyt SY3200 (Sony) 72 h after transfection. Sorted cells were individually cloned by dilution cloning and assessed by genotyping PCR and western blotting to obtain E-Syt1/2 DKO cells. E-Syt3 knockout: gBlock (IDT) comprising U6 promoter, human E-Syt3 target sequence and guide RNA was synthesized as described previously 47 . gBlock was amplified using gRNA_F and gRNA_R primers 47 ; target sequences used were P1S, P2AS, P2S and P2AS.
PCR genotyping was carried out using the primer set 5 ESYT3_TM_F2 and 3 ESYT3_TM_R2, which generates a 573 bp fragment in the control.
Four PCR products containing the individual guide RNA expression system together with hCas9 47 were co-transfected in E-Syt1/2 DKO (line 6-8 described in the results) HeLa cells. Cells were then individually cloned by dilution cloning 72 h after transfection and assessed by genotyping PCR to obtain E-Syt1/2/3 TKO cells.
The sequences of oligonucleotides and primers used are listed in Supplementary  Table 2 .
Sequencing of mutant alleles. Sequencing of mutated alleles was carried out by cloning PCR products into the pCR4 Blunt-TOPO vector using the Zero Blunt TOPO PCR cloning kit for sequencing (Life Technologies). Biallelic insertions/deletions were confirmed by sequencing at least 10 individual colonies. The same primers were used as genotyping primers.
Statistics and reproducibility.
No statistical method was used to predetermine sample size. The experiments were not randomized. Comparisons of data were carried out by either two-tailed Student's t-tests or t-tests with Bonferroni correction for multiple comparisons (multiplicity adjusted P values are shown in the case of multiple comparisons) as appropriate with Prism 6 (GraphPad software).
Immunofluorescence experiments were repeated three times with similar results, and representative images are shown in Fig. 1a, and Supplementary Fig. 1b .
Live cell imaging experiments were repeated three times with similar results, and representative images are shown in Figs 1d,g,i, 4c,e and 7g and Supplementary Figs 1c  and 3b .
Image analysis data in Figs 1h,j and 5b are from a single experiment, but representative of three independent experiments with similar results. All other assays were repeated at least two times.
Multiple electron micrographs were acquired from different beads and a representative image is shown in Fig. 4d .
For biochemical analyses when n was less than five experiments, individual data points are shown: Figs 2g, 4g,h and 6c and Supplementary Fig. 2a .
Western blotting and immunoprecipitation experiments shown in Fig. 1c ,e were done once, and the results were confirmed by fluorescence imaging experiments shown in Fig. 1d ,f, respectively. Experiments shown in Fig. 3b were repeated two times with similar results, and representative images are shown; these results were confirmed by additional experiments shown in Supplementary Figs 3e,f,g. Experiments in Supplementary Fig. 1a were repeated two times with similar results, and representative images are shown. Experiments shown in Fig. 4f were repeated three times with similar results, and representative images are shown. All of the uncropped images are shown in Supplementary Fig. 7 . 
